Evidence map›Paper›PMID 42391321›Full record

ArticleCirculation research2026

SBK2 Links Cardiac Stress Signaling to Mitochondrial Proteostasis.

Taylor M Coughlin, Catherine A Makarewich

Abstract readEditorial
In one paragraph

Article in Circulation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Taylor M CoughlinDivision of Molecular Cardiovascular Biology, The Heart Institute, Cincinnati Children's Hospital Medical Center, OH (T.M.C., C.A.M.).ORCID 0000-0001-8721-7306
Catherine A MakarewichDivision of Molecular Cardiovascular Biology, The Heart Institute, Cincinnati Children's Hospital Medical Center, OH (T.M.C., C.A.M.).ORCID 0000-0001-6907-4401

Funding

Microprotein Regulation of Mitochondrial FunctionR01HL160569 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI Catherine A Makarewich · 2022 to 2026
$2.0M
Developing DWORF gene therapy to treat heart failure and muscular dystrophyR01HL171221 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI Catherine A Makarewich, Jeffery D Molkentin · 2024 to 2026
$1.8M
Characterization of Nrac, a Novel Cardiac and Adipose Enriched MicroproteinF31HL178081 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI Taylor Coughlin · 2025 to 2026
$86k
NHLBI NIH HHS F31 HL178081NHLBI NIH HHS R01 HL160569NHLBI NIH HHS R01 HL171221
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Editorialsheart failurehypertrophymitochondriaoxidative phosphorylationproteostasis

Identifiers

PMID42391321
PMCPMC13336241

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.